Abstract:Background: The infiltration and activation of immune cells in the tumor microenvironment (TIME) affect the prognosis of patients with cancer. Tertiary lymphoid structure (TLS) formation favors tumour- infiltrating-lymphocyte (TIL) recruitment and is regarded as an important indicator of good prognosis associated with immunotherapy in patients with tumors. Chemotherapy is currently one of the most commonly used clinical treatment methods. However, there have been no clear report to explore the effects of different types of chemotherapy on TLS formation in the TIME. This study examined the effects of immunogenic cell death (ICD)-inducing chemotherapeutics on immune cells, high-endothelial venules (HEV), and TLSs in mouse melanomas. Methods: Doxorubicin (an ICD inducer), gemcitabine (non-ICD inducer), and a combination of the two drugs was delivered intra-peritoneally to B16F1-loaded C57BL/6 mice. The infiltration of immune cells into tumor tissues was evaluated using flow cytometry. HEV and TLS formation was assessed using immunohistochemistry and multiple fluorescent immunohistochemical staining. Results: Doxorubicin alone, gemcitabine alone, and the two-drug combination all slowed tumor growth, with the combined treatment demonstrating a more pronounced effect. Compared with the control group, the doxorubicin group showed a higher infiltration of CD8 + T cells and tissue-resident memory T cells (T RM ) and an increase in the secretion of interferon-γ, granzyme B, and perforin in CD8 + T subsets and activation of B cells and dendritic cells. Doxorubicin alone and in combination with gemcitabine decreased regulatory T cells in the TIME. Moreover, doxorubicin treatment promoted the formation of HEV and TLS. Doxorubicin treatment also upregulated the expression of programmed cell death protein (PD)-1 in CD8 + T cells and programmed cell death protein ligand (PD-L)1 in tumor cells. Conclusions: These results indicate that doxorubicin with an ICD reaction promotes TLS formation and increases PD-1/PD-L1 expression in tumor tissues. The results demonstrate the development of a therapeutic avenue using combined immune checkpoint therapy.

Comparison of direct and indirect low-temperature plasma triggering immunogenic cell death in B16F10 melanoma

Immunogenic Cell death Induced by Low Temperature Plasma to Activate Antitumor Immunity and Enhance Therapeutic Efficiency

Effect and mechanism of low-temperature plasma on the quantity and function of Treg and CD8+ T cells in B16-F10 melanoma-bearing mice

Low-Temperature Plasma Induced Melanoma Apoptosis By Triggering A P53/Pigs/Caspase-Dependent Pathway In Vivo And In Vitro

Preparation of a Plasma‐Induced Dendritic Cell Vaccine and Its Anti‐Tumor Immunity in a Murine Model of Melanoma

Viability Reduction of Melanoma Cells by Plasma Jet Via Inducing G1/S and G2/M Cell Cycle Arrest and Cell Apoptosis

Non-thermal plasma-induced immunogenic cell death in cancer

Comparison of Direct and Indirect cold atmospheric-pressure plasma methods in the B16F10 melanoma cancer cells treatment

Low Temperature Plasma Activated Liquid Induces Melanoma Apoptosis in Vivo and in Vitro

On the Mechanism of Plasma Inducing Cell Apoptosis

Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner

Intratumoral Injection Of Dendritic Cells In Combination With Local Hyperthermia Induces Systemic Antitumor Effect In Patients With Advanced Melanoma

Research Advances and Application Prospect of Low-Temperature Plasma in Tumor Immunotherapy

Nanosecond-Pulsed DBD Plasma-Generated Reactive Oxygen Species Trigger Immunogenic Cell Death in A549 Lung Carcinoma Cells through Intracellular Oxidative Stress

Inactivation Effect of Argon Atmospheric Pressure Low-Temperature Plasma Jet on Murine Melanoma Cells

Phototherapy-Induced Antitumor Immunity: Long-Term Tumor Suppression Effects Via Photoinactivation of Respiratory Chain Oxidase-Triggered Superoxide Anion Burst.

Effects of immunogenic cell death-inducing chemotherapeutics on the immune cell activation and tertiary lymphoid structure formation in melanoma

The analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells

Antitumor Efficacy Induced By A B16f10 Tumor Cell Vaccine Treated With Mitoxantrone Alone Or In Combination With Reserpine And Verapamil In Mice

Low‐temperature Plasma‐activated Medium Inhibited Invasion and Metastasis of Melanoma Cells Via Suppressing the Wnt/β‐catenin Pathway

Hypoxia Alleviated and One Photo-Triggered Thermal/Dynamic Nanoplatform for Immunogenic Cell Death-Initiated Cancer Immunotherapy